Global Hemostat Powder and Hemostatic Agents Supply, Demand and Key Producers, 2023-2029
Page: 123
Published Date: 30 Aug 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Hemostat Powder and Hemostatic Agents market size is expected to reach $ 2121.8 million by 2029, rising at a market growth of 5.0% CAGR during the forecast period (2023-2029).
The Hemostat Powder and Hemostatic Agents market has grown due to their crucial role in managing bleeding during surgical procedures and trauma situations. These agents, available in powder, gel, or sponge forms, promote blood clotting and accelerate the coagulation process. They are used to control bleeding in various medical settings, from surgeries to emergency situations, reducing the risk of excessive blood loss. As medical advancements continue, the demand for effective hemostatic solutions has risen. The market's expansion is driven by their versatility, quick action, and ability to address bleeding complications in diverse medical scenarios, ensuring improved patient outcomes and facilitating efficient medical interventions.
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
This report studies the global Hemostat Powder and Hemostatic Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hemostat Powder and Hemostatic Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hemostat Powder and Hemostatic Agents that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hemostat Powder and Hemostatic Agents total production and demand, 2018-2029, (K Units)
Global Hemostat Powder and Hemostatic Agents total production value, 2018-2029, (USD Million)
Global Hemostat Powder and Hemostatic Agents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hemostat Powder and Hemostatic Agents consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hemostat Powder and Hemostatic Agents domestic production, consumption, key domestic manufacturers and share
Global Hemostat Powder and Hemostatic Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hemostat Powder and Hemostatic Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hemostat Powder and Hemostatic Agents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Hemostat Powder and Hemostatic Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include J&J, Baxter, BD, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer and CSL Behring, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hemostat Powder and Hemostatic Agents market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hemostat Powder and Hemostatic Agents Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Hemostat Powder and Hemostatic Agents Market, Segmentation by Type
Microfibrillar Collagen
Chitosan
Global Hemostat Powder and Hemostatic Agents Market, Segmentation by Application
Minimally Invasive Surgery
Ordinary Surgery
Other
Companies Profiled:
J&J
Baxter
BD
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
Key Questions Answered
1. How big is the global Hemostat Powder and Hemostatic Agents market?
2. What is the demand of the global Hemostat Powder and Hemostatic Agents market?
3. What is the year over year growth of the global Hemostat Powder and Hemostatic Agents market?
4. What is the production and production value of the global Hemostat Powder and Hemostatic Agents market?
5. Who are the key producers in the global Hemostat Powder and Hemostatic Agents market?
Table of Contents
1 Supply Summary
1.1 Hemostat Powder and Hemostatic Agents Introduction
1.2 World Hemostat Powder and Hemostatic Agents Supply & Forecast
1.2.1 World Hemostat Powder and Hemostatic Agents Production Value (2018 & 2022 & 2029)
1.2.2 World Hemostat Powder and Hemostatic Agents Production (2018-2029)
1.2.3 World Hemostat Powder and Hemostatic Agents Pricing Trends (2018-2029)
1.3 World Hemostat Powder and Hemostatic Agents Production by Region (Based on Production Site)
1.3.1 World Hemostat Powder and Hemostatic Agents Production Value by Region (2018-2029)
1.3.2 World Hemostat Powder and Hemostatic Agents Production by Region (2018-2029)
1.3.3 World Hemostat Powder and Hemostatic Agents Average Price by Region (2018-2029)
1.3.4 North America Hemostat Powder and Hemostatic Agents Production (2018-2029)
1.3.5 Europe Hemostat Powder and Hemostatic Agents Production (2018-2029)
1.3.6 China Hemostat Powder and Hemostatic Agents Production (2018-2029)
1.3.7 Japan Hemostat Powder and Hemostatic Agents Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hemostat Powder and Hemostatic Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hemostat Powder and Hemostatic Agents Major Market Trends
2.1 World Hemostat Powder and Hemostatic Agents Demand (2018-2029)
2.2 World Hemostat Powder and Hemostatic Agents Consumption by Region
2.2.1 World Hemostat Powder and Hemostatic Agents Consumption by Region (2018-2023)
2.2.2 World Hemostat Powder and Hemostatic Agents Consumption Forecast by Region (2024-2029)
2.3 United States Hemostat Powder and Hemostatic Agents Consumption (2018-2029)
2.4 China Hemostat Powder and Hemostatic Agents Consumption (2018-2029)
2.5 Europe Hemostat Powder and Hemostatic Agents Consumption (2018-2029)
2.6 Japan Hemostat Powder and Hemostatic Agents Consumption (2018-2029)
2.7 South Korea Hemostat Powder and Hemostatic Agents Consumption (2018-2029)
2.8 ASEAN Hemostat Powder and Hemostatic Agents Consumption (2018-2029)
2.9 India Hemostat Powder and Hemostatic Agents Consumption (2018-2029)
3.1 World Hemostat Powder and Hemostatic Agents Production Value by Manufacturer (2018-2023)
3.2 World Hemostat Powder and Hemostatic Agents Production by Manufacturer (2018-2023)
3.3 World Hemostat Powder and Hemostatic Agents Average Price by Manufacturer (2018-2023)
3.4 Hemostat Powder and Hemostatic Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hemostat Powder and Hemostatic Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hemostat Powder and Hemostatic Agents in 2022
3.5.3 Global Concentration Ratios (CR8) for Hemostat Powder and Hemostatic Agents in 2022
3.6 Hemostat Powder and Hemostatic Agents Market: Overall Company Footprint Analysis
3.6.1 Hemostat Powder and Hemostatic Agents Market: Region Footprint
3.6.2 Hemostat Powder and Hemostatic Agents Market: Company Product Type Footprint
3.6.3 Hemostat Powder and Hemostatic Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Hemostat Powder and Hemostatic Agents Production Value Comparison
4.1.1 United States VS China: Hemostat Powder and Hemostatic Agents Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Hemostat Powder and Hemostatic Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Hemostat Powder and Hemostatic Agents Production Comparison
4.2.1 United States VS China: Hemostat Powder and Hemostatic Agents Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hemostat Powder and Hemostatic Agents Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Hemostat Powder and Hemostatic Agents Consumption Comparison
4.3.1 United States VS China: Hemostat Powder and Hemostatic Agents Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Hemostat Powder and Hemostatic Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Hemostat Powder and Hemostatic Agents Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Hemostat Powder and Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value (2018-2023)
4.4.3 United States Based Manufacturers Hemostat Powder and Hemostatic Agents Production (2018-2023)
4.5 China Based Hemostat Powder and Hemostatic Agents Manufacturers and Market Share
4.5.1 China Based Hemostat Powder and Hemostatic Agents Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value (2018-2023)
4.5.3 China Based Manufacturers Hemostat Powder and Hemostatic Agents Production (2018-2023)
4.6 Rest of World Based Hemostat Powder and Hemostatic Agents Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Hemostat Powder and Hemostatic Agents Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Hemostat Powder and Hemostatic Agents Production (2018-2023)
5.1 World Hemostat Powder and Hemostatic Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Microfibrillar Collagen
5.2.2 Chitosan
5.3 Market Segment by Type
5.3.1 World Hemostat Powder and Hemostatic Agents Production by Type (2018-2029)
5.3.2 World Hemostat Powder and Hemostatic Agents Production Value by Type (2018-2029)
5.3.3 World Hemostat Powder and Hemostatic Agents Average Price by Type (2018-2029)
6.1 World Hemostat Powder and Hemostatic Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Minimally Invasive Surgery
6.2.2 Ordinary Surgery
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Hemostat Powder and Hemostatic Agents Production by Application (2018-2029)
6.3.2 World Hemostat Powder and Hemostatic Agents Production Value by Application (2018-2029)
6.3.3 World Hemostat Powder and Hemostatic Agents Average Price by Application (2018-2029)
7.1 J&J
7.1.1 J&J Details
7.1.2 J&J Major Business
7.1.3 J&J Hemostat Powder and Hemostatic Agents Product and Services
7.1.4 J&J Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 J&J Recent Developments/Updates
7.1.6 J&J Competitive Strengths & Weaknesses
7.2 Baxter
7.2.1 Baxter Details
7.2.2 Baxter Major Business
7.2.3 Baxter Hemostat Powder and Hemostatic Agents Product and Services
7.2.4 Baxter Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Baxter Recent Developments/Updates
7.2.6 Baxter Competitive Strengths & Weaknesses
7.3 BD
7.3.1 BD Details
7.3.2 BD Major Business
7.3.3 BD Hemostat Powder and Hemostatic Agents Product and Services
7.3.4 BD Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 BD Recent Developments/Updates
7.3.6 BD Competitive Strengths & Weaknesses
7.4 B Braun
7.4.1 B Braun Details
7.4.2 B Braun Major Business
7.4.3 B Braun Hemostat Powder and Hemostatic Agents Product and Services
7.4.4 B Braun Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 B Braun Recent Developments/Updates
7.4.6 B Braun Competitive Strengths & Weaknesses
7.5 Gelita
7.5.1 Gelita Details
7.5.2 Gelita Major Business
7.5.3 Gelita Hemostat Powder and Hemostatic Agents Product and Services
7.5.4 Gelita Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Gelita Recent Developments/Updates
7.5.6 Gelita Competitive Strengths & Weaknesses
7.6 Integra Life Sciences
7.6.1 Integra Life Sciences Details
7.6.2 Integra Life Sciences Major Business
7.6.3 Integra Life Sciences Hemostat Powder and Hemostatic Agents Product and Services
7.6.4 Integra Life Sciences Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Integra Life Sciences Recent Developments/Updates
7.6.6 Integra Life Sciences Competitive Strengths & Weaknesses
7.7 Advance Medical Solution
7.7.1 Advance Medical Solution Details
7.7.2 Advance Medical Solution Major Business
7.7.3 Advance Medical Solution Hemostat Powder and Hemostatic Agents Product and Services
7.7.4 Advance Medical Solution Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Advance Medical Solution Recent Developments/Updates
7.7.6 Advance Medical Solution Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Hemostat Powder and Hemostatic Agents Product and Services
7.8.4 Pfizer Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 CSL Behring
7.9.1 CSL Behring Details
7.9.2 CSL Behring Major Business
7.9.3 CSL Behring Hemostat Powder and Hemostatic Agents Product and Services
7.9.4 CSL Behring Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 CSL Behring Recent Developments/Updates
7.9.6 CSL Behring Competitive Strengths & Weaknesses
7.10 CryoLife
7.10.1 CryoLife Details
7.10.2 CryoLife Major Business
7.10.3 CryoLife Hemostat Powder and Hemostatic Agents Product and Services
7.10.4 CryoLife Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 CryoLife Recent Developments/Updates
7.10.6 CryoLife Competitive Strengths & Weaknesses
7.11 Zimmer Biomet
7.11.1 Zimmer Biomet Details
7.11.2 Zimmer Biomet Major Business
7.11.3 Zimmer Biomet Hemostat Powder and Hemostatic Agents Product and Services
7.11.4 Zimmer Biomet Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Zimmer Biomet Recent Developments/Updates
7.11.6 Zimmer Biomet Competitive Strengths & Weaknesses
7.12 Ferrosan Medical Devices
7.12.1 Ferrosan Medical Devices Details
7.12.2 Ferrosan Medical Devices Major Business
7.12.3 Ferrosan Medical Devices Hemostat Powder and Hemostatic Agents Product and Services
7.12.4 Ferrosan Medical Devices Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Ferrosan Medical Devices Recent Developments/Updates
7.12.6 Ferrosan Medical Devices Competitive Strengths & Weaknesses
7.13 Medtronic
7.13.1 Medtronic Details
7.13.2 Medtronic Major Business
7.13.3 Medtronic Hemostat Powder and Hemostatic Agents Product and Services
7.13.4 Medtronic Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Medtronic Recent Developments/Updates
7.13.6 Medtronic Competitive Strengths & Weaknesses
7.14 Smith & Nephew
7.14.1 Smith & Nephew Details
7.14.2 Smith & Nephew Major Business
7.14.3 Smith & Nephew Hemostat Powder and Hemostatic Agents Product and Services
7.14.4 Smith & Nephew Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Smith & Nephew Recent Developments/Updates
7.14.6 Smith & Nephew Competitive Strengths & Weaknesses
7.15 Z-Medica
7.15.1 Z-Medica Details
7.15.2 Z-Medica Major Business
7.15.3 Z-Medica Hemostat Powder and Hemostatic Agents Product and Services
7.15.4 Z-Medica Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Z-Medica Recent Developments/Updates
7.15.6 Z-Medica Competitive Strengths & Weaknesses
7.16 Cohera Medical
7.16.1 Cohera Medical Details
7.16.2 Cohera Medical Major Business
7.16.3 Cohera Medical Hemostat Powder and Hemostatic Agents Product and Services
7.16.4 Cohera Medical Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Cohera Medical Recent Developments/Updates
7.16.6 Cohera Medical Competitive Strengths & Weaknesses
7.17 Marine Polymer
7.17.1 Marine Polymer Details
7.17.2 Marine Polymer Major Business
7.17.3 Marine Polymer Hemostat Powder and Hemostatic Agents Product and Services
7.17.4 Marine Polymer Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Marine Polymer Recent Developments/Updates
7.17.6 Marine Polymer Competitive Strengths & Weaknesses
7.18 Equimedical
7.18.1 Equimedical Details
7.18.2 Equimedical Major Business
7.18.3 Equimedical Hemostat Powder and Hemostatic Agents Product and Services
7.18.4 Equimedical Hemostat Powder and Hemostatic Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Equimedical Recent Developments/Updates
7.18.6 Equimedical Competitive Strengths & Weaknesses
8.1 Hemostat Powder and Hemostatic Agents Industry Chain
8.2 Hemostat Powder and Hemostatic Agents Upstream Analysis
8.2.1 Hemostat Powder and Hemostatic Agents Core Raw Materials
8.2.2 Main Manufacturers of Hemostat Powder and Hemostatic Agents Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hemostat Powder and Hemostatic Agents Production Mode
8.6 Hemostat Powder and Hemostatic Agents Procurement Model
8.7 Hemostat Powder and Hemostatic Agents Industry Sales Model and Sales Channels
8.7.1 Hemostat Powder and Hemostatic Agents Sales Model
8.7.2 Hemostat Powder and Hemostatic Agents Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Hemostat Powder and Hemostatic Agents Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Hemostat Powder and Hemostatic Agents Production Value by Region (2018-2023) & (USD Million)
Table 3. World Hemostat Powder and Hemostatic Agents Production Value by Region (2024-2029) & (USD Million)
Table 4. World Hemostat Powder and Hemostatic Agents Production Value Market Share by Region (2018-2023)
Table 5. World Hemostat Powder and Hemostatic Agents Production Value Market Share by Region (2024-2029)
Table 6. World Hemostat Powder and Hemostatic Agents Production by Region (2018-2023) & (K Units)
Table 7. World Hemostat Powder and Hemostatic Agents Production by Region (2024-2029) & (K Units)
Table 8. World Hemostat Powder and Hemostatic Agents Production Market Share by Region (2018-2023)
Table 9. World Hemostat Powder and Hemostatic Agents Production Market Share by Region (2024-2029)
Table 10. World Hemostat Powder and Hemostatic Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Hemostat Powder and Hemostatic Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Hemostat Powder and Hemostatic Agents Major Market Trends
Table 13. World Hemostat Powder and Hemostatic Agents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Hemostat Powder and Hemostatic Agents Consumption by Region (2018-2023) & (K Units)
Table 15. World Hemostat Powder and Hemostatic Agents Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Hemostat Powder and Hemostatic Agents Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Hemostat Powder and Hemostatic Agents Producers in 2022
Table 18. World Hemostat Powder and Hemostatic Agents Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Hemostat Powder and Hemostatic Agents Producers in 2022
Table 20. World Hemostat Powder and Hemostatic Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Hemostat Powder and Hemostatic Agents Company Evaluation Quadrant
Table 22. World Hemostat Powder and Hemostatic Agents Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Hemostat Powder and Hemostatic Agents Production Site of Key Manufacturer
Table 24. Hemostat Powder and Hemostatic Agents Market: Company Product Type Footprint
Table 25. Hemostat Powder and Hemostatic Agents Market: Company Product Application Footprint
Table 26. Hemostat Powder and Hemostatic Agents Competitive Factors
Table 27. Hemostat Powder and Hemostatic Agents New Entrant and Capacity Expansion Plans
Table 28. Hemostat Powder and Hemostatic Agents Mergers & Acquisitions Activity
Table 29. United States VS China Hemostat Powder and Hemostatic Agents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Hemostat Powder and Hemostatic Agents Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Hemostat Powder and Hemostatic Agents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Hemostat Powder and Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Hemostat Powder and Hemostatic Agents Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Hemostat Powder and Hemostatic Agents Production Market Share (2018-2023)
Table 37. China Based Hemostat Powder and Hemostatic Agents Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Hemostat Powder and Hemostatic Agents Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Hemostat Powder and Hemostatic Agents Production Market Share (2018-2023)
Table 42. Rest of World Based Hemostat Powder and Hemostatic Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Hemostat Powder and Hemostatic Agents Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Hemostat Powder and Hemostatic Agents Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Hemostat Powder and Hemostatic Agents Production Market Share (2018-2023)
Table 47. World Hemostat Powder and Hemostatic Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Hemostat Powder and Hemostatic Agents Production by Type (2018-2023) & (K Units)
Table 49. World Hemostat Powder and Hemostatic Agents Production by Type (2024-2029) & (K Units)
Table 50. World Hemostat Powder and Hemostatic Agents Production Value by Type (2018-2023) & (USD Million)
Table 51. World Hemostat Powder and Hemostatic Agents Production Value by Type (2024-2029) & (USD Million)
Table 52. World Hemostat Powder and Hemostatic Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Hemostat Powder and Hemostatic Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Hemostat Powder and Hemostatic Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Hemostat Powder and Hemostatic Agents Production by Application (2018-2023) & (K Units)
Table 56. World Hemostat Powder and Hemostatic Agents Production by Application (2024-2029) & (K Units)
Table 57. World Hemostat Powder and Hemostatic Agents Production Value by Application (2018-2023) & (USD Million)
Table 58. World Hemostat Powder and Hemostatic Agents Production Value by Application (2024-2029) & (USD Million)
Table 59. World Hemostat Powder and Hemostatic Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Hemostat Powder and Hemostatic Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 61. J&J Basic Information, Manufacturing Base and Competitors
Table 62. J&J Major Business
Table 63. J&J Hemostat Powder and Hemostatic Agents Product and Services
Table 64. J&J Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. J&J Recent Developments/Updates
Table 66. J&J Competitive Strengths & Weaknesses
Table 67. Baxter Basic Information, Manufacturing Base and Competitors
Table 68. Baxter Major Business
Table 69. Baxter Hemostat Powder and Hemostatic Agents Product and Services
Table 70. Baxter Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Baxter Recent Developments/Updates
Table 72. Baxter Competitive Strengths & Weaknesses
Table 73. BD Basic Information, Manufacturing Base and Competitors
Table 74. BD Major Business
Table 75. BD Hemostat Powder and Hemostatic Agents Product and Services
Table 76. BD Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. BD Recent Developments/Updates
Table 78. BD Competitive Strengths & Weaknesses
Table 79. B Braun Basic Information, Manufacturing Base and Competitors
Table 80. B Braun Major Business
Table 81. B Braun Hemostat Powder and Hemostatic Agents Product and Services
Table 82. B Braun Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. B Braun Recent Developments/Updates
Table 84. B Braun Competitive Strengths & Weaknesses
Table 85. Gelita Basic Information, Manufacturing Base and Competitors
Table 86. Gelita Major Business
Table 87. Gelita Hemostat Powder and Hemostatic Agents Product and Services
Table 88. Gelita Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Gelita Recent Developments/Updates
Table 90. Gelita Competitive Strengths & Weaknesses
Table 91. Integra Life Sciences Basic Information, Manufacturing Base and Competitors
Table 92. Integra Life Sciences Major Business
Table 93. Integra Life Sciences Hemostat Powder and Hemostatic Agents Product and Services
Table 94. Integra Life Sciences Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Integra Life Sciences Recent Developments/Updates
Table 96. Integra Life Sciences Competitive Strengths & Weaknesses
Table 97. Advance Medical Solution Basic Information, Manufacturing Base and Competitors
Table 98. Advance Medical Solution Major Business
Table 99. Advance Medical Solution Hemostat Powder and Hemostatic Agents Product and Services
Table 100. Advance Medical Solution Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Advance Medical Solution Recent Developments/Updates
Table 102. Advance Medical Solution Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Hemostat Powder and Hemostatic Agents Product and Services
Table 106. Pfizer Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 110. CSL Behring Major Business
Table 111. CSL Behring Hemostat Powder and Hemostatic Agents Product and Services
Table 112. CSL Behring Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. CSL Behring Recent Developments/Updates
Table 114. CSL Behring Competitive Strengths & Weaknesses
Table 115. CryoLife Basic Information, Manufacturing Base and Competitors
Table 116. CryoLife Major Business
Table 117. CryoLife Hemostat Powder and Hemostatic Agents Product and Services
Table 118. CryoLife Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. CryoLife Recent Developments/Updates
Table 120. CryoLife Competitive Strengths & Weaknesses
Table 121. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
Table 122. Zimmer Biomet Major Business
Table 123. Zimmer Biomet Hemostat Powder and Hemostatic Agents Product and Services
Table 124. Zimmer Biomet Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Zimmer Biomet Recent Developments/Updates
Table 126. Zimmer Biomet Competitive Strengths & Weaknesses
Table 127. Ferrosan Medical Devices Basic Information, Manufacturing Base and Competitors
Table 128. Ferrosan Medical Devices Major Business
Table 129. Ferrosan Medical Devices Hemostat Powder and Hemostatic Agents Product and Services
Table 130. Ferrosan Medical Devices Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Ferrosan Medical Devices Recent Developments/Updates
Table 132. Ferrosan Medical Devices Competitive Strengths & Weaknesses
Table 133. Medtronic Basic Information, Manufacturing Base and Competitors
Table 134. Medtronic Major Business
Table 135. Medtronic Hemostat Powder and Hemostatic Agents Product and Services
Table 136. Medtronic Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Medtronic Recent Developments/Updates
Table 138. Medtronic Competitive Strengths & Weaknesses
Table 139. Smith & Nephew Basic Information, Manufacturing Base and Competitors
Table 140. Smith & Nephew Major Business
Table 141. Smith & Nephew Hemostat Powder and Hemostatic Agents Product and Services
Table 142. Smith & Nephew Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Smith & Nephew Recent Developments/Updates
Table 144. Smith & Nephew Competitive Strengths & Weaknesses
Table 145. Z-Medica Basic Information, Manufacturing Base and Competitors
Table 146. Z-Medica Major Business
Table 147. Z-Medica Hemostat Powder and Hemostatic Agents Product and Services
Table 148. Z-Medica Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Z-Medica Recent Developments/Updates
Table 150. Z-Medica Competitive Strengths & Weaknesses
Table 151. Cohera Medical Basic Information, Manufacturing Base and Competitors
Table 152. Cohera Medical Major Business
Table 153. Cohera Medical Hemostat Powder and Hemostatic Agents Product and Services
Table 154. Cohera Medical Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Cohera Medical Recent Developments/Updates
Table 156. Cohera Medical Competitive Strengths & Weaknesses
Table 157. Marine Polymer Basic Information, Manufacturing Base and Competitors
Table 158. Marine Polymer Major Business
Table 159. Marine Polymer Hemostat Powder and Hemostatic Agents Product and Services
Table 160. Marine Polymer Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Marine Polymer Recent Developments/Updates
Table 162. Equimedical Basic Information, Manufacturing Base and Competitors
Table 163. Equimedical Major Business
Table 164. Equimedical Hemostat Powder and Hemostatic Agents Product and Services
Table 165. Equimedical Hemostat Powder and Hemostatic Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 166. Global Key Players of Hemostat Powder and Hemostatic Agents Upstream (Raw Materials)
Table 167. Hemostat Powder and Hemostatic Agents Typical Customers
Table 168. Hemostat Powder and Hemostatic Agents Typical Distributors
List of Figure
Figure 1. Hemostat Powder and Hemostatic Agents Picture
Figure 2. World Hemostat Powder and Hemostatic Agents Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hemostat Powder and Hemostatic Agents Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Hemostat Powder and Hemostatic Agents Production (2018-2029) & (K Units)
Figure 5. World Hemostat Powder and Hemostatic Agents Average Price (2018-2029) & (US$/Unit)
Figure 6. World Hemostat Powder and Hemostatic Agents Production Value Market Share by Region (2018-2029)
Figure 7. World Hemostat Powder and Hemostatic Agents Production Market Share by Region (2018-2029)
Figure 8. North America Hemostat Powder and Hemostatic Agents Production (2018-2029) & (K Units)
Figure 9. Europe Hemostat Powder and Hemostatic Agents Production (2018-2029) & (K Units)
Figure 10. China Hemostat Powder and Hemostatic Agents Production (2018-2029) & (K Units)
Figure 11. Japan Hemostat Powder and Hemostatic Agents Production (2018-2029) & (K Units)
Figure 12. Hemostat Powder and Hemostatic Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hemostat Powder and Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 15. World Hemostat Powder and Hemostatic Agents Consumption Market Share by Region (2018-2029)
Figure 16. United States Hemostat Powder and Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 17. China Hemostat Powder and Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 18. Europe Hemostat Powder and Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 19. Japan Hemostat Powder and Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 20. South Korea Hemostat Powder and Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Hemostat Powder and Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 22. India Hemostat Powder and Hemostatic Agents Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Hemostat Powder and Hemostatic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hemostat Powder and Hemostatic Agents Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hemostat Powder and Hemostatic Agents Markets in 2022
Figure 26. United States VS China: Hemostat Powder and Hemostatic Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Hemostat Powder and Hemostatic Agents Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hemostat Powder and Hemostatic Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Hemostat Powder and Hemostatic Agents Production Market Share 2022
Figure 30. China Based Manufacturers Hemostat Powder and Hemostatic Agents Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Hemostat Powder and Hemostatic Agents Production Market Share 2022
Figure 32. World Hemostat Powder and Hemostatic Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Hemostat Powder and Hemostatic Agents Production Value Market Share by Type in 2022
Figure 34. Microfibrillar Collagen
Figure 35. Chitosan
Figure 36. World Hemostat Powder and Hemostatic Agents Production Market Share by Type (2018-2029)
Figure 37. World Hemostat Powder and Hemostatic Agents Production Value Market Share by Type (2018-2029)
Figure 38. World Hemostat Powder and Hemostatic Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Hemostat Powder and Hemostatic Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Hemostat Powder and Hemostatic Agents Production Value Market Share by Application in 2022
Figure 41. Minimally Invasive Surgery
Figure 42. Ordinary Surgery
Figure 43. Other
Figure 44. World Hemostat Powder and Hemostatic Agents Production Market Share by Application (2018-2029)
Figure 45. World Hemostat Powder and Hemostatic Agents Production Value Market Share by Application (2018-2029)
Figure 46. World Hemostat Powder and Hemostatic Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Hemostat Powder and Hemostatic Agents Industry Chain
Figure 48. Hemostat Powder and Hemostatic Agents Procurement Model
Figure 49. Hemostat Powder and Hemostatic Agents Sales Model
Figure 50. Hemostat Powder and Hemostatic Agents Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
J&J Baxter BD B Braun Gelita Integra Life Sciences Advance Medical Solution Pfizer CSL Behring CryoLife Zimmer Biomet Ferrosan Medical Devices Medtronic Smith & Nephew Z-Medica Cohera Medical Marine Polymer Equimedical
Related Reports
30 Aug 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
